88 related articles for article (PubMed ID: 19327905)
1. Radiotherapy for pancreatic neuroendocrine tumors.
Contessa JN; Griffith KA; Wolff E; Ensminger W; Zalupski M; Lawrence TS; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1196-200. PubMed ID: 19327905
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
Arvold ND; Willett CG; Fernandez-del Castillo C; Ryan DP; Ferrone CR; Clark JW; Blaszkowsky LS; Deshpande V; Niemierko A; Allen JN; Kwak EL; Wadlow RC; Zhu AX; Warshaw AL; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e337-43. PubMed ID: 22414286
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of radiotherapy for primary tumor in patients with unresectable pancreatic neuroendocrine tumors.
Iwata T; Ueno H; Itami J; Ito Y; Inaba K; Morizane C; Kondo S; Sakamoto Y; Shiba S; Sasaki M; Koga F; Okusaka T
Jpn J Clin Oncol; 2017 Sep; 47(9):826-831. PubMed ID: 28591817
[TBL] [Abstract][Full Text] [Related]
4. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
[TBL] [Abstract][Full Text] [Related]
5. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
[TBL] [Abstract][Full Text] [Related]
6. Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy.
Zagar TM; White RR; Willett CG; Tyler DS; Papavassiliou P; Papalezova KT; Guy CD; Broadwater G; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1126-31. PubMed ID: 22270161
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of everolimus in gastrointestinal and pancreatic neuroendocrine tumors after (177)Lu-octreotate.
Kamp K; Gumz B; Feelders RA; Kwekkeboom DJ; Kaltsas G; Costa FP; de Herder WW
Endocr Relat Cancer; 2013 Dec; 20(6):825-31. PubMed ID: 24036133
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
9. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma.
Chan EK; Fung S; Gospodarowicz M; Hodgson D; Wells W; Sun A; Pintile M; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e781-6. PubMed ID: 21167657
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome and toxicity after dose-intensified treatment with 131I-MIBG for advanced metastatic carcinoid tumors.
Ezziddin S; Sabet A; Logvinski T; Alkawaldeh K; Yong-Hing CJ; Ahmadzadehfar H; Grünwald F; Biersack HJ
J Nucl Med; 2013 Dec; 54(12):2032-8. PubMed ID: 24101685
[TBL] [Abstract][Full Text] [Related]
11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
12. The role of palliative radiation therapy in symptomatic locally advanced gastric cancer.
Tey J; Back MF; Shakespeare TP; Mukherjee RK; Lu JJ; Lee KM; Wong LC; Leong CN; Zhu M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):385-8. PubMed ID: 17118569
[TBL] [Abstract][Full Text] [Related]
13. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma.
Olivier KR; Schild SE; Morris CG; Brown PD; Markovic SN
Cancer; 2007 Oct; 110(8):1791-5. PubMed ID: 17721993
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Wang J; Xia TY; Wang YJ; Li HQ; Li P; Wang JD; Chang DS; Liu LY; Di YP; Wang X; Wu WZ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e59-65. PubMed ID: 21345607
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
16. Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.
Nomura N; Fujii T; Kanazumi N; Takeda S; Nomoto S; Kasuya H; Sugimoto H; Yamada S; Nakao A
J Hepatobiliary Pancreat Surg; 2009; 16(5):639-47. PubMed ID: 19365596
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?
Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M
JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627
[TBL] [Abstract][Full Text] [Related]
18. Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy.
Combs SE; Salehi-Allameh B; Habermehl D; Kessel KA; Welzel T; Debus J
Head Neck; 2014 Jan; 36(1):22-7. PubMed ID: 23649985
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis.
Valentini V; Morganti AG; Macchia G; Mantini G; Mattiucci GC; Brizi MG; Alfieri S; Bossola M; Pacelli F; Sofo L; Doglietto G; Cellini N
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1094-9. PubMed ID: 18313525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
